Ischemia and Trauma-Different Etiologies Similar Mechanisms: Neuroprotective Opportunities. Brain Research. Brain Reviews, 39(1), 55-73.
Long, J.Z., Nomura, D.K., Vann, R.E., Walentiny, D.M., Booker, L., Jin, X.,…& Cravatt, B.F. (2009). Dual Blockade of FAAH and MAGL Identifies Behavioral Processes Regulated by Endocannabinoid Crosstalk In Vivo. Proceedings of the National Academy of Science of the United States of America, (106)48, 20270-20275.
Lu, H. & Mackie, K. (2016). An Introduction to the Endocannabinoid System. Biological Psychiatry, 79(7), 516-525.
Lutz, B., Marsicano, G., Maldonado, R. & Hillard, C.J. (2015). The Endocannabinoid System in Guarding Against Fear, Anxiety, and Stress. Nature Science Reviews, 16(12), 705-718.
Maccarrone, M., Bab, I., Biro, T., Cabral, G., Dey, S.K., Di Marzo, V.,...& Zimmer, A. (2015). Endocannabinoid Signaling at the Periphery: 50 Years After THC. Trends in Pharmacological Sciences, 36(5), 277–296.
Maccarrone, M. & Finazzi-Agro, A. (2003). The Endocannabinoid System, Anandamide, and the Regulation of Mammalian Cell Apoptosis. Cell Death and Differentiation, 10, 946-955.
Mahvan, T.D., Hilaire, M.L., Mann, A., Brown, A., Linn, B., Gardner, T., & Lai, B. (2017). Marijuana Use in the Elderly: Implications and Considerations. Consultant Pharmacist Forum, 32(6), 341-351.
Maltoni, M., Scarpi, E. & Nanni, O. (2014). Palliative Sedation for Intolerable Suffering. Current Opinion in Oncology, 26(4), 389–394.
Maresz, K., Ponomarev, E.D., Carrier, E.J., Hillard, C.J. & Dittel, B.N. (2005). Modulation of the Cannabinoid CB2 Receptor in Microglial Cells in Response to Inflammatory Stimuli. Journal of Neurochemistry, 95(2), 437-445.
Marijuana in Combination with Opioids in Palliative and Hospice Patients, Clinical Trial. (2017). Current page on U.S. National Library of Medicine ClinicalTrails.gov website (page last updated 08/31/2017). Information on page provided by (Responsible Party): Theodore Zanker MD, The Connecticut Hospice Inc. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT03233633
Martin, A. (2017, August 22). This Hospice Is Hoping to Prove That Cannabis Can Make Dying Less Painful. BuzzFeed News. Retrieved from: https://www.buzzfeed.com/alysonmartin/this-hospice-is-hoping-to-prove-that-cannabis-can-make?utm_term=.kapgo4ALY#.ctOE3k78Y
McPartland, J.M., Guy, G.W. & Di Marzo, V. (2014). Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System. Plos One, 9(3), 1-21.
McPartland, J.M. & Pruitt, P.L. (1997). Medical Marijuana and its Use by the Immunocompromised. Alternative Therapies in Health and Medicine, 3(3), 39-45.
McPartland, J.M. & Russo, E.B. (2001). Cannabis and Cannabis Extracts: Greater than the Sum of Their Parts? Journal of Cannabis Therapeutics (The Haworth Press, Inc.), 1(3/4), 103-132.
Mechoulam, R. (2010). Head Trauma, Neuroprotection, and Cannabinoids. Presentation at The Sixth National Clinical Conference on Cannabis Therapeutics, April 16-17, 2010, Warwick, Rhode Island. Retrieved from https://www.youtube.com/watch?v=RU68-SRNPOg
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N., Schatz, A.,…& Compton, D. et al. (1995). Identification of an Endogenous 2-Monoglyceride, Present in Canine Gut, that Binds to Cannabinoid Receptors. Biochemical Pharmacology, 50(1):83-90.
Mechoulam, R., Panikashvili, D. & Shohami, E. (2002). Cannabinoids and Brain injury: Therapeutic Implications. Trends in Molecular Medicine, 8(2):58-61.
More, S.V.& Choi, D.K. (2015). Promising Cannabinoid Based Therapies for Parkinson’s Disease:
Motor Symptoms to Neuroprotection. Molecular Neurodegeneration, 10(17), 1-26.
Moriera, F.A. & Crippa, J.A. (2009). The Psychiatric Side-effects of Rimonabant. Revista Brasiliera Psiquiatria, 31(2), 145-153.
Munro, S., Thomas, K.L. & Abu-Sharr, M. (1993). Molecular Characterization of a Peripheral Receptor for Cannabinoids. Nature, 365, 61-65.
Najjar, S., Pearlman., Alper, K., Najjar, A. & Devinsky, O. (2013). Neuroinflammation and Psychiatric Illness. Journal of Neuroinflammation, 10(43), 1-24.
Pancher, P. & Hasko, G. (2008). Endocannabinoids and Cannabinoid Receptors in Ischaemia-Reperfusion Injury and Preconditioning. British Journal of Pharmacology, 153(2), 252-262
Parker, Linda. (2017). Cannabinoids and the Brain. Cambridge, MA: The MIT Press.
Pertwee, R.G. (2008). Ligands That Target Cannabinoid Receptors in the Brain: From THC to Anandamide and Beyond. Addiction Biology, 13(2), 147-159.
Petrosino, S., Ligresti, A. & Di Marzo, V. (2009). Endocannabinoid Chemical Biology: A Tool for the Development of Novel Therapies. Current Opinion in Chemical Biology, 13(3), 309-320.
Pype, P., Teuwen, I., Mertens, F., Sercu, M. & De Sutter, A. (2017). Suboptimal Palliative Sedation in Primary Care: An Exploration. Acta Clinica Belgica, June 5, 1-8.
Ruchlemer, R., Amit-Kohn, M., Raveh, D., & Hanus, L. (2015). Inhaled Medicinal Cannabis and the Immunocompromised Patient. Supportive Care in Cancer, 23(3):819-22.
Russo E.B. (2001). Hemp for Headache: An In-depth Historical and Scientific Review of Cannabis in Migraine Treatment. Journal of Cannabis Therapeutics, 1, 21–92.
Russo, E.B. (2015). Synthetic and Natural Cannabinoids: The Cardiovascular Risk. The British Journal of Cardiology, Editorial, 22(1), 7-9.
Russo, E.B. (2016a). The Endocannabinoid System in Health and Disease. Presentation at The United In Compassion Medicinal Cannabis Symposium, June 14th & 15th, Sydney, Australia. Retrieved from: https://www.youtube.com/watch?v=1s-dDGTt20c&index=3&list=PL9Eh5xA-yu4ZUfSi-jQD-kWsMN3EOG5eb&t=23s
Russo, E.B. (2016b). Beyond Cannabis: Plants and the Endocannabinoid System. Trends in Pharmacological Sciences, 37(7), 594-605.
Russo, E.B & Guy, G.W. (2006). A Tale of Two Cannabinoids: The Therapeutic Rationale for Combining Tetrahydrocannabinol and Cannabidiol. Medical Hypotheses, 66(2), 234-46.
Santosh, V. & Sravya, P. (2017). Glioma, Glutamate (SLC7A11) And Seizures-A Commentary. Annals of Translational Medicine, 5(10), 214.
Scotter, E.L., Abood, M.E. & Glass, M. (2010). The Endocannabinoid System as a Target for the
Treatment of Neurodegenerative Disease. British Journal of Pharmacology, 160(3),
480-498.
Shi, S., & Klotz, U. (2011). Age-Related Changes in Pharmacokinetics. Current Drug Metabolism, 12(7), 601-10.
Shohami, E., Cohen-Yeshurun, A., Magid, L., Algali, M. & Mechoulam, R. (2011). Endocannabinoids and Traumatic Brain Injury. British Journal of Pharmacology, 163(7), 1402-1410.
Singh G., Rees J.H. & Sander, J.W. (2007). Seizures and Epilepsy in Oncological Practice: Causes, Course, Mechanisms and Treatment. Journal of Neurology, Neurosurgery and Psychiatry, 78(4), 342–9.
Sizoo, E.M., Braam, L., Postma, T.J., Roeline, H., Pasman, W., Heimans…& Taphoorn, M.J.B. (2010). Symptoms and Problems in the End-of-life Phase of High Grade Glioma Patients. Neuro-Oncology, 12(11), 1162-1166.
Sugiura, T. & Waku, K. (2000). 2-Arachidonoylglycerol and the Cannabinoid Receptors. Chemistry and Physics of Lipids, 108(1-2), 89-106.
Sulak, D., Saneto, R. & Goldstein, B. (February 28, 2017). Medical Marijuana for Seizures. Published on projectcbd.org. Retrieved from: https://www.projectcbd.org/article/medical-marijuana-seizures-sulak-saneto-goldstein
Theisen, Eloise. (2017). Cannabis for Seniors: Reducing Pharmaceuticals and Improving Quality of Life. Green Flower Media (www.learngreenflower.com). Original date of 2017 lecture unavailable. Retrieved from: https://www.learngreenflower.com/courses/63/Cannabis-For-Seniors-Reducing-Pharmaceuticals-and-Improving-Quality-of-Life
Torres, A., Linker, W., Land, D., & Gaudino, R. (2017). Study of Pesticides in Clones: Research Summary. Published by Steep Hill Labs, Inc., September 22. Retrieved from: https://landing.steephill.com/cleanclones
Tradounsky, G. (2013). Seizures in Palliative Care. Canadian Family Physician, 59(9), 951-955.
The United States of America As Represented by the Department of Health and Human Services, Original Assignee. Medicinal Acidic Cannabinoids. US patent 7807711 B2, issued January 27, 2011. Retrieved from: https://www.google.ch/patents/US7807711
Waldman, M., Hochhauser, E., Fishbein, M., Aravot, D., Shainberg., A. & Sarne, Y. (2013). An Ultra-low Dose of Tetrahydrocannabinol Provides Cardioprotection. Biochemical Pharmacology, 85(11), 1626-33.
Wallace, M., Martin, B. & DeLorenzo, R.J. (2002). Evidence for a Physiological Role of Endocannabinoids in Modulation of Seizure Threshold and Severity. European Journal of Pharmacology, 452, 295-301.
World Health Organization Essential Medicines in Palliative Care, Executive Summary. (2013). Houston: International Association for Hospice and Palliative Care.
Zendulka, O., Dovrtelova, G., Noskova, K., Turjap, M., Sulcova, A., Hanus, L., & Jurica, J. (2016). Cannabinoids and Cytochrome P450 Interactions. Current Drug Metabolism, 17(3), 206-226.
REFERENCES-Difficult Road Of Dying